Neurologic Disorder Treatment Drug Market, Global Outlook and Forecast 2022-2028

July 2022 | 103 pages | ID: N7B99998B720EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Neurologic Disorder Treatment Drug in Global, including the following market information:

Global Neurologic Disorder Treatment Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neurologic Disorder Treatment Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anticholinergic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurologic Disorder Treatment Drug include AbbVie, Acadia Pharmaceuticals, Acorda Therapeutics Biotechnology, Bayer, Biogen, CSK, Eisai, F. Hoffmann La Roche and H Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurologic Disorder Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurologic Disorder Treatment Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neurologic Disorder Treatment Drug Market Segment Percentages, by Type, 2021 (%)

• Anticholinergic
• Antiepileptic
• Antipsychotic
• Hypnotic and Sedative
• Analgesics
• Antihypertensive
• Anticoagulants
• Others

Global Neurologic Disorder Treatment Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neurologic Disorder Treatment Drug Market Segment Percentages, by Application, 2021 (%)

• Epilepsy
• Alzheimer’s Disease
• Parkinson's Disease
• Multiple Sclerosis
• Cerebrovascular Disease
• Others

Global Neurologic Disorder Treatment Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neurologic Disorder Treatment Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neurologic Disorder Treatment Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neurologic Disorder Treatment Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Acadia Pharmaceuticals
• Acorda Therapeutics Biotechnology
• Bayer
• Biogen
• CSK
• Eisai
• F. Hoffmann La Roche
• H Lundbeck
• Johnson and Johnson
• Merck
• Novartis
• Otsuka Pharmaceutical
• Pfizer
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• UCB
• USWM

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neurologic Disorder Treatment Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neurologic Disorder Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROLOGIC DISORDER TREATMENT DRUG OVERALL MARKET SIZE

2.1 Global Neurologic Disorder Treatment Drug Market Size: 2021 VS 2028
2.2 Global Neurologic Disorder Treatment Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neurologic Disorder Treatment Drug Players in Global Market
3.2 Top Global Neurologic Disorder Treatment Drug Companies Ranked by Revenue
3.3 Global Neurologic Disorder Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Neurologic Disorder Treatment Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neurologic Disorder Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Players in Global Market
  3.6.1 List of Global Tier 1 Neurologic Disorder Treatment Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neurologic Disorder Treatment Drug Market Size Markets, 2021 & 2028
  4.1.2 Anticholinergic
  4.1.3 Antiepileptic
  4.1.4 Antipsychotic
  4.1.5 Hypnotic and Sedative
  4.1.6 Analgesics
  4.1.7 Antihypertensive
  4.1.8 Anticoagulants
  4.1.9 Others
4.2 By Type - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
  4.2.1 By Type - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
  4.2.2 By Type - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
  4.2.3 By Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neurologic Disorder Treatment Drug Market Size, 2021 & 2028
  5.1.2 Epilepsy
  5.1.3 Alzheimer’s Disease
  5.1.4 Parkinson's Disease
  5.1.5 Multiple Sclerosis
  5.1.6 Cerebrovascular Disease
  5.1.7 Others
5.2 By Application - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
  5.2.1 By Application - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
  5.2.2 By Application - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
  5.2.3 By Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neurologic Disorder Treatment Drug Market Size, 2021 & 2028
6.2 By Region - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
  6.2.1 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2017-2022
  6.2.2 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2023-2028
  6.2.3 By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neurologic Disorder Treatment Drug Revenue, 2017-2028
  6.3.2 US Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.3.3 Canada Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.3.4 Mexico Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neurologic Disorder Treatment Drug Revenue, 2017-2028
  6.4.2 Germany Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.3 France Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.4 U.K. Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.5 Italy Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.6 Russia Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.4.8 Benelux Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neurologic Disorder Treatment Drug Revenue, 2017-2028
  6.5.2 China Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.5.3 Japan Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.5.4 South Korea Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.5.6 India Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neurologic Disorder Treatment Drug Revenue, 2017-2028
  6.6.2 Brazil Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.6.3 Argentina Neurologic Disorder Treatment Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, 2017-2028
  6.7.2 Turkey Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.7.3 Israel Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Neurologic Disorder Treatment Drug Market Size, 2017-2028
  6.7.5 UAE Neurologic Disorder Treatment Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Neurologic Disorder Treatment Drug Major Product Offerings
  7.1.4 AbbVie Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Acadia Pharmaceuticals
  7.2.1 Acadia Pharmaceuticals Corporate Summary
  7.2.2 Acadia Pharmaceuticals Business Overview
  7.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Major Product Offerings
  7.2.4 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.2.5 Acadia Pharmaceuticals Key News
7.3 Acorda Therapeutics Biotechnology
  7.3.1 Acorda Therapeutics Biotechnology Corporate Summary
  7.3.2 Acorda Therapeutics Biotechnology Business Overview
  7.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Major Product Offerings
  7.3.4 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.3.5 Acorda Therapeutics Biotechnology Key News
7.4 Bayer
  7.4.1 Bayer Corporate Summary
  7.4.2 Bayer Business Overview
  7.4.3 Bayer Neurologic Disorder Treatment Drug Major Product Offerings
  7.4.4 Bayer Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.4.5 Bayer Key News
7.5 Biogen
  7.5.1 Biogen Corporate Summary
  7.5.2 Biogen Business Overview
  7.5.3 Biogen Neurologic Disorder Treatment Drug Major Product Offerings
  7.5.4 Biogen Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.5.5 Biogen Key News
7.6 CSK
  7.6.1 CSK Corporate Summary
  7.6.2 CSK Business Overview
  7.6.3 CSK Neurologic Disorder Treatment Drug Major Product Offerings
  7.6.4 CSK Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.6.5 CSK Key News
7.7 Eisai
  7.7.1 Eisai Corporate Summary
  7.7.2 Eisai Business Overview
  7.7.3 Eisai Neurologic Disorder Treatment Drug Major Product Offerings
  7.7.4 Eisai Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.7.5 Eisai Key News
7.8 F. Hoffmann La Roche
  7.8.1 F. Hoffmann La Roche Corporate Summary
  7.8.2 F. Hoffmann La Roche Business Overview
  7.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Major Product Offerings
  7.8.4 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.8.5 F. Hoffmann La Roche Key News
7.9 H Lundbeck
  7.9.1 H Lundbeck Corporate Summary
  7.9.2 H Lundbeck Business Overview
  7.9.3 H Lundbeck Neurologic Disorder Treatment Drug Major Product Offerings
  7.9.4 H Lundbeck Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.9.5 H Lundbeck Key News
7.10 Johnson and Johnson
  7.10.1 Johnson and Johnson Corporate Summary
  7.10.2 Johnson and Johnson Business Overview
  7.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Major Product Offerings
  7.10.4 Johnson and Johnson Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.10.5 Johnson and Johnson Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Neurologic Disorder Treatment Drug Major Product Offerings
  7.11.4 Merck Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News
7.12 Novartis
  7.12.1 Novartis Corporate Summary
  7.12.2 Novartis Business Overview
  7.12.3 Novartis Neurologic Disorder Treatment Drug Major Product Offerings
  7.12.4 Novartis Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.12.5 Novartis Key News
7.13 Otsuka Pharmaceutical
  7.13.1 Otsuka Pharmaceutical Corporate Summary
  7.13.2 Otsuka Pharmaceutical Business Overview
  7.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
  7.13.4 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.13.5 Otsuka Pharmaceutical Key News
7.14 Pfizer
  7.14.1 Pfizer Corporate Summary
  7.14.2 Pfizer Business Overview
  7.14.3 Pfizer Neurologic Disorder Treatment Drug Major Product Offerings
  7.14.4 Pfizer Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.14.5 Pfizer Key News
7.15 Sanofi
  7.15.1 Sanofi Corporate Summary
  7.15.2 Sanofi Business Overview
  7.15.3 Sanofi Neurologic Disorder Treatment Drug Major Product Offerings
  7.15.4 Sanofi Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.15.5 Sanofi Key News
7.16 Takeda Pharmaceutical
  7.16.1 Takeda Pharmaceutical Corporate Summary
  7.16.2 Takeda Pharmaceutical Business Overview
  7.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
  7.16.4 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.16.5 Takeda Pharmaceutical Key News
7.17 Teva Pharmaceutical Industries
  7.17.1 Teva Pharmaceutical Industries Corporate Summary
  7.17.2 Teva Pharmaceutical Industries Business Overview
  7.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Major Product Offerings
  7.17.4 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.17.5 Teva Pharmaceutical Industries Key News
7.18 UCB
  7.18.1 UCB Corporate Summary
  7.18.2 UCB Business Overview
  7.18.3 UCB Neurologic Disorder Treatment Drug Major Product Offerings
  7.18.4 UCB Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.18.5 UCB Key News
7.19 USWM
  7.19.1 USWM Corporate Summary
  7.19.2 USWM Business Overview
  7.19.3 USWM Neurologic Disorder Treatment Drug Major Product Offerings
  7.19.4 USWM Neurologic Disorder Treatment Drug Revenue in Global Market (2017-2022)
  7.19.5 USWM Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neurologic Disorder Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Neurologic Disorder Treatment Drug Market Drivers in Global Market
Table 3. Neurologic Disorder Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Neurologic Disorder Treatment Drug in Global Market
Table 5. Top Neurologic Disorder Treatment Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neurologic Disorder Treatment Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neurologic Disorder Treatment Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neurologic Disorder Treatment Drug Product Type
Table 9. List of Global Tier 1 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neurologic Disorder Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Neurologic Disorder Treatment Drug Product Offerings
Table 32. AbbVie Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 33. Acadia Pharmaceuticals Corporate Summary
Table 34. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offerings
Table 35. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 36. Acorda Therapeutics Biotechnology Corporate Summary
Table 37. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offerings
Table 38. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Neurologic Disorder Treatment Drug Product Offerings
Table 41. Bayer Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 42. Biogen Corporate Summary
Table 43. Biogen Neurologic Disorder Treatment Drug Product Offerings
Table 44. Biogen Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 45. CSK Corporate Summary
Table 46. CSK Neurologic Disorder Treatment Drug Product Offerings
Table 47. CSK Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 48. Eisai Corporate Summary
Table 49. Eisai Neurologic Disorder Treatment Drug Product Offerings
Table 50. Eisai Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 51. F. Hoffmann La Roche Corporate Summary
Table 52. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offerings
Table 53. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 54. H Lundbeck Corporate Summary
Table 55. H Lundbeck Neurologic Disorder Treatment Drug Product Offerings
Table 56. H Lundbeck Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 57. Johnson and Johnson Corporate Summary
Table 58. Johnson and Johnson Neurologic Disorder Treatment Drug Product Offerings
Table 59. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Neurologic Disorder Treatment Drug Product Offerings
Table 62. Merck Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 63. Novartis Corporate Summary
Table 64. Novartis Neurologic Disorder Treatment Drug Product Offerings
Table 65. Novartis Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 66. Otsuka Pharmaceutical Corporate Summary
Table 67. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 68. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 69. Pfizer Corporate Summary
Table 70. Pfizer Neurologic Disorder Treatment Drug Product Offerings
Table 71. Pfizer Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 72. Sanofi Corporate Summary
Table 73. Sanofi Neurologic Disorder Treatment Drug Product Offerings
Table 74. Sanofi Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 75. Takeda Pharmaceutical Corporate Summary
Table 76. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 77. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 78. Teva Pharmaceutical Industries Corporate Summary
Table 79. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offerings
Table 80. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 81. UCB Corporate Summary
Table 82. UCB Neurologic Disorder Treatment Drug Product Offerings
Table 83. UCB Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 84. USWM Corporate Summary
Table 85. USWM Neurologic Disorder Treatment Drug Product Offerings
Table 86. USWM Neurologic Disorder Treatment Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neurologic Disorder Treatment Drug Segment by Type in 2021
Figure 2. Neurologic Disorder Treatment Drug Segment by Application in 2021
Figure 3. Global Neurologic Disorder Treatment Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neurologic Disorder Treatment Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neurologic Disorder Treatment Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurologic Disorder Treatment Drug Revenue in 2021
Figure 8. By Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 12. US Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 16. Germany Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 24. China Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biogen Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CSK Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eisai Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. H Lundbeck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novartis Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pfizer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sanofi Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. UCB Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. USWM Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)